Showing results (171-180 of 377) with videos related to
Sort By:
Pageof 38
Journal for Immunotherapy of Cancer|February 2, 2023
BRCA1 deficiency in mature CD8+ T lymphocytes impairs antitumor immunityBogang Wu, Leilei Qi, Huai-Chin Chiang, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2021
Inhibiting Fatty Acid Synthase with Omeprazole to Improve Efficacy of Neoadjuvant Chemotherapy in Patients with Operable TNBCSagar D Sardesai, Alexandra Thomas, Christopher Gallagher, et al.Breast Cancer Research and Treatment|August 2, 2025
Neoadjuvant HER2-targeted regimens with or without anthracyclines for HER2-positive inflammatory breast cancer: a multicenter retrospective studyToshiaki Iwase, Nithya Sridhar, Megumi Kai, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 4, 2024
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology GuidelineIsabelle Bedrosian, Mark R Somerfield, Maria Isabel Achatz, et al.Journal of the National Cancer Institute|January 11, 2012
Estrogen metabolism and risk of breast cancer in postmenopausal womenBarbara J Fuhrman, Catherine Schairer, Mitchell H Gail, et al.Journal of Genetic Counseling|February 7, 2023
Measuring high-risk parents' opinions about direct-to-consumer genetic testing for adult-onset inherited cancer syndromes in their adolescent and young adult childrenEmily Hasser, Beth N Peshkin, Jada G Hamilton, et al.Community Genetics|July 9, 2004
The Cancer Genetics Network: recruitment results and pilot studiesHoda Anton-Culver, Argyrios Ziogas, Deborah Bowen, et al.Journal of Genetic Counseling|July 5, 2015
Development of an Interactive Decision Aid for Female BRCA1/BRCA2 CarriersElizabeth M Kaufman, Beth N Peshkin, William F Lawrence, et al.Biorxiv : the Preprint Server for Biology|September 5, 2025
Organoid-evaluable clinical biomarkers predict drug responses and guide new breast cancer therapiesTam Binh V Bui, Denise M Wolf, Michael C Bruck, et al.JAMA Oncology|June 14, 2019
Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast CancerShaveta Vinayak, Sara M Tolaney, Lee Schwartzberg, et al.Pageof 38